GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Agimexpharm Pharmaceutical JSC (HSTC:AGP) » Definitions » EPS (Basic)

Agimexpharm Pharmaceutical JSC (HSTC:AGP) EPS (Basic) : ₫ (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Agimexpharm Pharmaceutical JSC EPS (Basic)?

Agimexpharm Pharmaceutical JSC's basic earnings per share (Basic EPS) for the six months ended in . 20 was ₫0.00. Agimexpharm Pharmaceutical JSC does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Agimexpharm Pharmaceutical JSC's EPS (Diluted) for the six months ended in . 20 was ₫0.00. Agimexpharm Pharmaceutical JSC does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Agimexpharm Pharmaceutical JSC's EPS without NRI for the six months ended in . 20 was ₫0.00. Agimexpharm Pharmaceutical JSC does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Agimexpharm Pharmaceutical JSC EPS (Basic) Historical Data

The historical data trend for Agimexpharm Pharmaceutical JSC's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agimexpharm Pharmaceutical JSC EPS (Basic) Chart

Agimexpharm Pharmaceutical JSC Annual Data
Trend
EPS (Basic)

Agimexpharm Pharmaceutical JSC Semi-Annual Data
EPS (Basic)

Agimexpharm Pharmaceutical JSC EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Agimexpharm Pharmaceutical JSC's Basic EPS for the fiscal year that ended in . 20 is calculated as


Agimexpharm Pharmaceutical JSC's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agimexpharm Pharmaceutical JSC  (HSTC:AGP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Agimexpharm Pharmaceutical JSC EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Agimexpharm Pharmaceutical JSC's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Agimexpharm Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
27 Nguyen Thai Hoc, My Binh Ward, An Giang Province, Long Xuyen, VNM
Agimexpharm Pharmaceutical JSC is engaged in manufacturing of pharmaceuticals, medicinal chemicals and botanical products.

Agimexpharm Pharmaceutical JSC Headlines

No Headlines